Risk assessment for continuous flow left ventricular assist devices: Does the destination therapy risk score work?: An analysis of over 1,000 patients

Journal of the American College of Cardiology

Volumn 60, Issue 1, 2012, Pages 44-51

  Teuteberg, Jeffrey J ^a   Ewald, Greg A ^b   Adamson, Robert M ^c   Lietz, Katherine ^d   Miller, Leslie W ^e   Tatooles, Antone J ^f   Kormos, Robert L ^a   Sundareswaran, Kartik S ^g   Farrar, David J ^g   Rogers, Joseph G ^h  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SHARP MEMORIAL HOSPITAL   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f ADVOCATE CHRIST MEDICAL CENTER   (United States)

^g THORATEC CORPORATION   (United States)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

left ventricular assist device; mechanical circulatory support; risk stratification

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; CORRELATIONAL STUDY; DESTINATION THERAPY RISK SCORE; FEMALE; HIGH RISK POPULATION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; COHORT STUDIES; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HEART-ASSIST DEVICES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PULSATILE FLOW; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84862882255     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.032     Document Type: Article

References (17)

1. M.S. Slaughter, J.G. Rogers, C.A. Milano HeartMate II Investigators Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
2. J.K. Kirklin, D.C. Naftel, R.L. Kormos Third INTERMACS annual report: the evolution of destination therapy in the United States J Heart Lung Transplant 30 2011 115 123
3. L.W. Miller, F.D. Pagani, S.D. Russell HeartMate II Clinical Investigators Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
4. F.D. Pagani, L.W. Miller, S.D. Russell HeartMate II Investigators Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J Am Coll Cardiol 54 2009 312 321
5. R. John, Y. Naka, N.G. Smedira Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial Ann Thorac Surg 92 2011 1406 1413 discussion 1413
6. A.J. Boyle, D.D. Ascheim, M.J. Russo Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification J Heart Lung Transplant 30 2011 402 407
7. K.D. Aaronson, J.S. Schwartz, T.M. Chen, K.L. Wong, J.E. Goin, D.M. Mancini Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660 2667
8. J.R. Fitzpatrick 3rd, J.R. Frederick, V.M. Hsu Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support J Heart Lung Transplant 27 2008 1286 1292
9. W.C. Levy, D. Mozaffarian, D.T. Linker The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
10. K. Lietz, J.W. Long, A.G. Kfoury Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection Circulation 116 2007 497 505
11. V. Rao, M.C. Oz, M.A. Flannery, K.A. Catanese, M. Argenziano, Y. Naka Revised screening scale to predict survival after insertion of a left ventricular assist device J Thorac Cardiovasc Surg 125 2003 855 862
12. M.C. Oz, D.J. Goldstein, P. Pepino Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices Circulation 92 1995 II169 II173
13. J.K. Kirklin, D.C. Naftel, R.L. Kormos Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants J Heart Lung Transplant 29 2010 1 10
14. J.M. Schaffer, J.G. Allen, E.S. Weiss Evaluation of risk indices in continuous-flow left ventricular assist device patients Ann Thorac Surg 88 2009 1889 1896
15. J.K. Kirklin, D.C. Naftel, R.L. Kormos The fourth INTERMACS annual report: 4,000 implants and counting J Heart Lung Transplant 31 2012 117 126
16. R.C. Starling, Y. Naka, A.J. Boyle Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 57 2011 1890 1898
17. E.A. Rose, A.C. Gelijns, A.J. Moskowitz REMATCH Study Group Long-term mechanical left ventricular assistance for end-stage heart failure N Engl J Med 345 2001 1435 1443